Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
Recruiting
N/A
Interventional Study
Pharmacokinetics
Amoxicillin-clavulanate
Piperacillin-tazobactam
Meropenem
Cefazolin
Teicoplanin
Vancomycin
Ciprofloxacin
Amikacin
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- Up to 15
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 300 (estimated)
- Sponsor
- University Hospital, Ghent · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Pharmacokinetics of antibiotics in critically ill neonates, infants and children on extracorporeal membrane oxygenation (ECMO).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients admitted to the pediatric intensive care unit or cardiac intensive care unit
* patient age : 1,8 kg-15 years
* patient receiving antibiotic treatment (piperacillin-tazobactam, meropenem, amoxicillin-clavulanate, cephazolin, vancomycin, teicoplanin, ciprofloxacin, amik…
Contacts